MedPath

A comparative study to access the homoeopathic management of urolithiasis from individualized medicinal approach vs organopathic hydrangea arborescens approach

Phase 3
Conditions
Health Condition 1: N202- Calculus of kidney with calculus of ureter
Registration Number
CTRI/2024/04/066098
Lead Sponsor
Dr m p k Homoeopathic Medical College Hospital And Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Cases both asymptomatic and symptomatic with radiological evidence of urolithiasis

Cases giving consent for study

Diagnosed cases who have taken medicines from any other system of treatment will also be consider after a wash out period of 15 days

All socioeconomic status

Exclusion Criteria

Patient not willing to give consent

Patient with major systemic disorder and autoimmune diseases

Cases with hydronephrosis uti uremia acute retention of urine for more than 24 hours

Cases of staghorn calculi.

Gross developmental or structural anomalies

Pregnant women and lactating mothers are not included

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment as per pre and post uss score chart and radiological evidence usg or xray pre and post treatment <br/ ><br>From this study we expect that hydrangea arborescens or individualized homoeopathic medicines will give beneficial results in the management of cases of urolithiasis <br/ ><br>Helpful in enriching existing materia materia and improve the knowledge of clinicians and further encourage future researcherTimepoint: Follow up at regular interval of 15 or early if required or as per the requirement of the case <br/ ><br>Final assessment at 9 months or 3 months prior to the conclusion of study
Secondary Outcome Measures
NameTimeMethod
At the end it will widen the approach to manage the cases of urolithiasis and we may expect better management from homoeopathic medicinesTimepoint: 12 months
© Copyright 2025. All Rights Reserved by MedPath